Dawes Karen A insider trades
Dawes Karen A has filed 23 Form 4s with the SEC that we hold, for Repligen Corp (RGEN) (Director) and Barinthus Biotherapeutics plc. (BRNS) (Director). Across all of them we count 0 purchases worth $0 and 57 sales worth $12.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($44.3K). The largest single trade was a sale of 8,580 shares of Repligen Corp worth $2.2M, dated 2021-08-17. The first filing on our record is dated 2021-07-15 and the latest 2026-09-09.
Repligen Corp (RGEN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-13 | S, sale reported on Form 4 | 5 | $1.0K | 2021-07-22 |
| 2021-07-13 | S, sale reported on Form 4 | 441 | $88.8K | 2021-07-22 |
| 2021-07-13 | S, sale reported on Form 4 | 630 | $127.4K | 2021-07-22 |
| 2021-07-13 | S, sale reported on Form 4 | 444 | $90.2K | 2021-07-22 |
| 2021-07-13 | S, sale reported on Form 4 | 1,520 | $307.4K | 2021-07-15 |
| 2021-07-20 | S, sale reported on Form 4 | 288 | $57.6K | 2021-07-22 |
| 2021-07-20 | S, sale reported on Form 4 | 806 | $162.3K | 2021-07-22 |
| 2021-07-20 | S, sale reported on Form 4 | 2,877 | $582.0K | 2021-07-22 |
| 2021-07-20 | S, sale reported on Form 4 | 614 | $124.7K | 2021-07-22 |
| 2021-08-17 | S, sale reported on Form 4 | 924 | $232.1K | 2021-08-19 |
| 2021-08-17 | S, sale reported on Form 4 | 920 | $231.8K | 2021-08-19 |
| 2021-08-17 | S, sale reported on Form 4 | 4,665 | $1.2M | 2021-08-19 |
| 2021-08-17 | S, sale reported on Form 4 | 8,580 | $2.2M | 2021-08-19 |
| 2021-08-17 | S, sale reported on Form 4 | 2,231 | $569.1K | 2021-08-19 |
| 2021-08-17 | S, sale reported on Form 4 | 194 | $49.7K | 2021-08-19 |
| 2021-08-18 | S, sale reported on Form 4 | 40 | $10.5K | 2021-08-19 |
| 2021-08-18 | S, sale reported on Form 4 | 302 | $77.8K | 2021-08-19 |
| 2021-08-18 | S, sale reported on Form 4 | 634 | $164.1K | 2021-08-19 |
| 2021-08-18 | S, sale reported on Form 4 | 388 | $100.9K | 2021-08-19 |
| 2021-08-18 | S, sale reported on Form 4 | 78 | $20.4K | 2021-08-19 |
| 2021-09-01 | S, sale reported on Form 4 | 239 | $67.0K | 2021-09-02 |
| 2021-09-01 | S, sale reported on Form 4 | 196 | $55.2K | 2021-09-02 |
| 2021-09-01 | S, sale reported on Form 4 | 851 | $242.9K | 2021-09-02 |
| 2021-09-01 | S, sale reported on Form 4 | 405 | $114.4K | 2021-09-02 |
| 2021-09-01 | S, sale reported on Form 4 | 661 | $187.4K | 2021-09-02 |
| 2021-09-01 | S, sale reported on Form 4 | 1,107 | $315.1K | 2021-09-02 |
| 2021-09-14 | S, sale reported on Form 4 | 108 | $31.9K | 2021-09-15 |
| 2021-09-14 | S, sale reported on Form 4 | 27 | $8.0K | 2021-09-15 |
| 2021-09-14 | S, sale reported on Form 4 | 25 | $7.3K | 2021-09-15 |
| 2021-09-14 | S, sale reported on Form 4 | 13 | $3.8K | 2021-09-15 |
| 2021-09-14 | S, sale reported on Form 4 | 101 | $29.7K | 2021-09-15 |
| 2021-11-02 | S, sale reported on Form 4 | 251 | $75.6K | 2021-11-04 |
| 2021-11-02 | S, sale reported on Form 4 | 64 | $19.1K | 2021-11-04 |
| 2021-11-02 | S, sale reported on Form 4 | 283 | $86.7K | 2021-11-04 |
| 2021-11-02 | S, sale reported on Form 4 | 700 | $214.1K | 2021-11-04 |
| 2021-11-02 | S, sale reported on Form 4 | 124 | $37.7K | 2021-11-04 |
| 2021-11-02 | S, sale reported on Form 4 | 532 | $161.5K | 2021-11-04 |
| 2021-11-02 | S, sale reported on Form 4 | 446 | $134.7K | 2021-11-04 |
| 2021-11-10 | S, sale reported on Form 4 | 1,119 | $294.6K | 2021-11-12 |
| 2021-11-10 | S, sale reported on Form 4 | 14 | $3.8K | 2021-11-12 |
| 2021-11-10 | S, sale reported on Form 4 | 462 | $120.0K | 2021-11-12 |
| 2021-11-10 | S, sale reported on Form 4 | 236 | $61.6K | 2021-11-12 |
| 2021-11-10 | S, sale reported on Form 4 | 1,038 | $272.2K | 2021-11-12 |
| 2021-11-10 | S, sale reported on Form 4 | 336 | $88.8K | 2021-11-12 |
| 2021-11-10 | S, sale reported on Form 4 | 488 | $129.5K | 2021-11-12 |
| 2021-11-10 | S, sale reported on Form 4 | 486 | $129.6K | 2021-11-12 |
| 2021-11-10 | S, sale reported on Form 4 | 349 | $93.4K | 2021-11-12 |
| 2021-11-10 | S, sale reported on Form 4 | 255 | $68.8K | 2021-11-12 |
| 2022-05-25 | S, sale reported on Form 4 | 2,576 | $384.3K | 2022-05-26 |
| 2022-05-25 | S, sale reported on Form 4 | 1,845 | $278.9K | 2022-05-26 |
| 2022-05-25 | S, sale reported on Form 4 | 1,875 | $285.3K | 2022-05-26 |
| 2022-05-25 | S, sale reported on Form 4 | 742 | $113.4K | 2022-05-26 |
| 2022-05-25 | S, sale reported on Form 4 | 7,677 | $1.2M | 2022-05-26 |
| 2022-09-09 | S, sale reported on Form 4 | 775 | $176.1K | 2022-09-09 |
| 2023-08-29 | S, sale reported on Form 4 | 850 | $145.7K | 2023-08-30 |
| 2024-02-27 | S, sale reported on Form 4 | 1,000 | $193.3K | 2024-02-28 |
| 2025-12-17 | S, sale reported on Form 4 | 275 | $44.3K | 2025-12-18 |
Barinthus Biotherapeutics plc. (BRNS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1261506) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms